ProMIS Neurosciences, Inc. (PMN)
9.035
+0.94
(+11.68%)
USD |
NASDAQ |
Oct 21, 16:00
9.035
0.00 (0.00%)
After-Hours: 18:51
ProMIS Neurosciences Net Income (Quarterly) : -11.73M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.73M |
| March 31, 2026 | -8.244M |
| December 31, 2025 | -10.67M |
| September 30, 2025 | -11.58M |
| June 30, 2025 | -10.12M |
| March 31, 2025 | -7.348M |
| December 31, 2024 | -0.2382M |
| September 30, 2024 | 9.276M |
| June 30, 2024 | -2.624M |
| March 31, 2024 | -3.635M |
| December 31, 2023 | -3.580M |
| September 30, 2023 | -2.361M |
| June 30, 2023 | -2.312M |
| March 31, 2023 | -4.959M |
| December 31, 2022 | -7.266M |
| September 30, 2022 | -5.957M |
| June 30, 2022 | -2.745M |
| March 31, 2022 | -2.431M |
| December 31, 2021 | -2.321M |
| September 30, 2021 | -0.7634M |
| June 30, 2021 | -0.2422M |
| March 31, 2021 | -6.002M |
| December 31, 2020 | -0.5266M |
| September 30, 2020 | -1.174M |
| June 30, 2020 | -1.191M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.310M |
| December 31, 2019 | -1.101M |
| September 30, 2019 | -1.240M |
| June 30, 2019 | -1.389M |
| March 31, 2019 | -1.840M |
| December 31, 2018 | -2.638M |
| September 30, 2018 | -2.228M |
| June 30, 2018 | -1.715M |
| March 31, 2018 | -1.231M |
| December 31, 2017 | -0.8855M |
| September 30, 2017 | -1.292M |
| June 30, 2017 | -1.416M |
| March 31, 2017 | -1.037M |
| December 31, 2016 | -0.9076M |
| September 30, 2016 | -0.6607M |
| June 30, 2016 | -0.5523M |
| March 31, 2016 | -0.4878M |
| December 31, 2015 | -0.5241M |
| September 30, 2015 | -0.5454M |
| June 30, 2015 | -0.2274M |
| March 31, 2015 | -0.3449M |
| December 31, 2014 | -0.4593M |
| September 30, 2014 | -0.6448M |
| June 30, 2014 | -0.8417M |
| March 31, 2014 | -0.6471M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Edesa Biotech, Inc. | -5.408M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 11.73M |
| EPS Diluted (Quarterly) | -1.283 |
| Enterprise Value | 19.09M |
| Earnings Yield | -148.7% |
| Normalized Earnings Yield | -148.70 |